ML | pharmaphorum

R&D

As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.

Oncology

Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

ML